Abstract
The mesenchymal stem cells and multipotent stromal cells (MSCs) have emerged in recent years as an excellent alternative to embryonic stem cells for their high plastic capacity and its immunomodulatory effects without inducing tumor formation and exhibiting lower ethical barriers in their therapeutic use. Bone marrow is the most used source of MSCs, however their invasive way of harvest a…